SCHEMBL6141364

SCHEMBL6141364

COc1cccc(OC)c1C(=O)[AsH]C(Cc1ccc2nc(-c3ccccc3[N+](=O)[O-])ccc2c1)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EIF4E P06730 2/20 0.38
ALDH1A1 P00352 6/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ITGB1 P05556 1/20 0.36
ITGAV P06756 1/20 0.36
MAPT P10636 5/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
NPSR1 Q6W5P4 1/20 0.34
HTT P42858 1/20 0.34
F2RL3 Q96RI0 1/20 0.34
ALPL P05186 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6141055 0.87 ITGB1 (0.38) EIF4EALDH1A1ITGB1ITGAVMAPT
SCHEMBL3315024 0.84 ITGB1 (0.54) ALDH1A1NPC1RAB9AITGB1ITGAV
SCHEMBL6140590 0.81 ITGB1 (0.56) ITGB1ITGAV
SCHEMBL6141756 0.79 ITGB1 (0.36) EIF4EALDH1A1NPC1RAB9AITGB1
SCHEMBL6140931 0.78 ITGB1 (0.54) ITGB1ITGAV
SCHEMBL3317071 0.72 ITGB1 (0.71) ITGB1ITGAV
SCHEMBL3318790 0.72 ITGB1 (0.56) ITGB1ITGAV
SCHEMBL3314454 0.72 ITGB1 (0.67) ALDH1A1ITGB1ITGAV
SCHEMBL3314476 0.71 ITGB1 (0.63) ITGB1ITGAV
SCHEMBL27602604 0.71 ITGB1 (0.63) ITGB1ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2005-02-02 EP disclosed
WO-2003093237-A1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS UCB, S.A. (BE) 2003-11-13 WO disclosed